Search
When Dave Norkin was diagnosed at 39 with a rare cancer, he was told he had just months to live. Now, a decade later, he’s surviving — thanks to the emerging field of theranostics, which combines imaging and therapy for a search-and-destroy mission.
Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.
Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and largest professional organization dedicated to advancing cancer research, and the press program highlights cancer research that a panel of AACR experts considers the most significant of the year and deserving of media attention.
An antibody that targets a protein specific to prostate cells can be used to image prostate cancer more clearly and indicate how well drugs are working.
Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
Learn about the 19 students who completed the 2019 Summer Undergraduate Research Program (SURP) at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
Dr. Tallman will serve a year-long term as President for the American Society of Hematology.
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce the distinguished MSK nurses who were honored with the 2025 Robbins Family Award for Nursing Excellence.
Semanti Mukherjee successfully defended her thesis in September 2011. Her project focused on the genetic variants that contribute to the predisposition for and etiology of myeloproliferative neoplasms.